Medical Device News Magazine

With Second Mevion Proton System Installed at Siteman Cancer Center, Additional Cancer Patients Begin Treatment

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Mevion Medical Systems announced today that patient treatment has commenced on the MEVION S250i Proton Therapy System® at the S. Lee Kling Proton Therapy Center at Siteman Cancer Center, based at Washington University School of Medicine and Barnes-Jewish Hospital in St. Louis. The new proton therapy system is located directly next to the first system, which was installed in 2013. Mevion is the only proton therapy provider capable of offering a truly modular room-by-room or 1+1 expansion.

Siteman Cancer Center, an NCI-designated Comprehensive Cancer Center, serves patients in Missouri, Southern Illinois, and beyond. Each year, hundreds of cancer patients treated at Siteman have received proton therapy, which is used to treat lung, brain, head and neck, gastrointestinal and gynecologic cancers, and other difficult-to-treat tumors. The growing number of patients treated with proton therapy has increased the need for a second system to accommodate demand.

The newest addition to the Kling Proton Center features Mevion’s industry-leading HYPERSCAN® technology and Adaptive Aperture® pMLC. HYPERSCAN provides faster and more precise targeted dose delivery to tumors and minimizes the damage to surrounding healthy tissue and sensitive organs at risk. Siteman has also integrated a high-resolution ceiling-mounted cone-beam CT system and a diagnostic CT on-rail system, enabling a state-of-art Image-Guided Proton Therapy (IGPT) configuration allowing their team to provide adaptive and hypofractionated proton therapy.

“During the past seven years, we have incorporated proton therapy into the treatment plans for hundreds of adult and pediatric cancer patients. Our ability to expand with a second system will enable us to continue to offer the latest technology to more patients and to expand the clinical use of proton therapy,” said Stephanie Perkins, M.D., director, S. Lee Kling Proton Therapy Center.

Scientists from Siteman and Mevion’s Advanced Development team have collaborated on ultra-high dose rate, FLASH therapy research. Last fall, the group successfully delivered over 200Gy/s dose rate on a Mevion production system and published a joint research paper in Medical Physics this May.

“We congratulate Siteman for starting treatment with their second Mevion system,” said Tina Yu, chief executive officer of Mevion Medical Systems. “Mevion is proud to deepen our collaboration with Siteman and look forward to discussing and developing next-generation technology and treatment protocols to expand the use of proton therapy on both systems.”

Medical Device News Magazine
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

HeartFlow Introduces Next Generation Interactive Plaque Analysis Platform to Assess Patient Risk in Suspected Coronary Artery Disease

The HeartFlow Plaque Analysis uses proprietary algorithms to analyze coronary CT angiogram (CCTA) scans, creating a personalized 3D model that quantifies and characterizes plaque volume in the coronary arteries, aiding risk assessment of coronary artery disease. The technology was introduced at the Society of Cardiovascular Computed Tomography (SCCT) Annual Scientific Meeting in Washington, D.C.

Ultrahuman Announces its App Store ‘PowerPlugs’ with the World’s First AFib Detection Technology on a Smart Ring

Recognizing each individual’s health journey is unique, PowerPlugs enable people to choose and focus on the aspects of their health that matter most. It’s designed for highly personalized health insights, ensuring that every individual can personalize their health tracking to their unique needs and goals.

VisionAir Solutions Celebrates Milestone and New Collaboration

This achievement marks VisionAir Solutions commitment to bringing technological innovation to pulmonary medicine. Since its acquisition by Theken Companies last year, VAS has over doubled its growth and continues to demonstrate industry adoption and the advantages of personalized healthcare.